Background and Objectives: Pediatric patients can acquire scars from both accidental injury and surgical procedures. While scars cannot be avoided if a full-thickness injury occurs, scar visibility may be minimized through a variety of approaches. In this narrative review, we evaluate the current evidence and propose an algorithm for scar management in pediatric patients. Materials and Methods: A review of the literature was performed for scar management techniques for pediatric patients. Management modalities based on the type of scar and dosing, treatment regimen, and safety profiles are described in this article and used to create a scar management algorithm. Results: The initial step to scar management in the pediatric population involves ensuring minimal wound tension, which can be achieved through making the incision along relaxed skin tension lines, and early, minimal tension wound closure. Subsequent treatments to optimize scar care should begin 2–3 weeks following wound closure and involve the application of silicone gel or sheets and scar massaging. When topical products are insufficient, laser therapy can be utilized for the management of immature erythematous or thick scars. When mature, pathological scars form such as atrophic scars, hyperpigmentation, hypertrophic scars, or keloids, a combination of modalities is recommended. These modalities vary by scar type and include retinoids and dermabrasion for atrophic scars; retinoids, hydroquinone, and laser therapy for hyperpigmentation; and pressure therapy, corticosteroids, and laser therapy for hypertrophic scars and keloids. When mature, pathological scars persist following 12 months of non-invasive therapies, surgical excision should be considered. Conclusions: Several treatment options are available to manage scars in the pediatric population depending on scar type.
15 February 2024 in Journal of Plastic, Reconstructive & Aesthetic Surgery
Facial masculinization surgery is a set of procedures for transmasculine patients, including mandible angle, chin, and tracheal augmentation. This study assesses outcomes and complications in 6 transmasculine patients who have undergone facial masculinization with poly (ether-ether ketone) (PEEK) implants following virtual surgical planning. Six patients were scanned preoperatively and personalized implants were created for each patient depending on their anatomy. Projection for the chin was calculated such that the most anterior portion of the chin postimplant is in line with the most anterior portion of the nasal spine. Projection for the mandibular angles was designed such that the width of each mandibular angle postimplant is 1 to 2 mm less than the width of the respective zygoma to give a tapered, but still prominent jawline. Patient characteristics such as demographic information and medical history were analyzed, in addition to intraoperative and postoperative complications and outcomes. A total of 12 procedures were performed, with the multiprocedures occurring in a single operation for each patient. All 6 patients had mandible augmentation, while 3 patients had chin augmentation and 3 had Adam's apple enhancement. All procedures utilized VSP for chin and mandibular angle implants. One patient, who did not take the prescribed postoperative antibiotics, developed a chin abscess that was treated with drainage and antibiotics. All patients were very satisfied with their results and no patients requested revisionary surgery. VSP for facial masculinization surgery allows gender affirming surgeons to tailor implants depending on specific patient anatomy, which increases patient satisfaction by giving patients ideal masculine proportions.
5 February 2025 in The American Journal of Surgery
Background: Transfeminine patients have anatomically male noses, although most surgeons perform rhinoplasties on female noses. Objectives: This study reports on the outcomes of feminizing rhinoplasty in 102 transfeminine patients and the reasons for revision. Methods: A retrospective review of patient characteristics was performed for 102 transfeminine patients who received feminizing rhinoplasty from January 2021 to February 2024. Multivariate regression was used to assess the relationship between the need for revision and patient characteristics. Results: Three patients (2.9%) experienced postoperative complications. One had postoperative hemorrhage requiring an ER visit and nasal packing, 1 had scar contracture at the alar base (after alar base resection), and 1 had chondritis requiring medrol and NSAIDs. Seventeen patients (16.7%) received revision surgery, citing 22 total reasons. Dorsal hump reduction (N=8, 36.4%) and tip revision (N=8, 36.4%) were the most common reasons, followed by a wide dorsum (N=3, 13.6%). Fourteen patients had a prior rhinoplasty or septoplasty, of which 14.3% (N=2) had revisions. Twenty-three percent of Caucasians (N=9), 50% of Asians (N=2), 22% of multiracial patients (N=6), and no African American and unspecified ethnicity patients underwent revision. Dorsal hump reduction was the most common revision reason for Caucasian and Asian patients, whereas multiracial patients equally cited dorsal hump reduction and poor tip rotation. No patient characteristics were significantly associated with revision. Conclusion: Revision surgery was not significantly associated with any patient characteristics. Patients most sought revision for dorsal hump reduction and tip revision. Surgeons and patients should discuss desired outcomes to minimize revision incidence.